Accelerated RBC senescence as a novel pathologic mechanism of blood stasis syndrome in traditional East Asian medicine

American Journal of Translational Research

Volumn 7, Issue 3, 2015, Pages 422-429

  You, Sooseong ^a   Park, Bongki ^a   Lee, Myeong Soo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Blood stasis syndrome; Red blood cell; Senescence

Indexed keywords

4 CARBOXYGLUTAMIC ACID; METHEMOGLOBIN; NITRIC OXIDE; SCRAMBLASE;

APOPTOSIS; BLOOD STASIS SYNDROME; CELL ACTIVATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE SENESCENCE; HEMATOLOGIC DISEASE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; METHEMOGLOBINEMIA; OXIDATIVE STRESS; PROTEIN DEGRADATION; REVIEW; SENESCENCE; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TRADITIONAL MEDICINE; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 84929998444     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Li SM, Xu H and Chen KJ. The diagnostic criteria of blood-stasis syndrome: considerations for standardization of pattern identification. Chin J Integr Med 2014; 20: 483-489.
2. Park B, You S, Jung J, Lee JA, Yun KJ and Lee MS. Korean Studies on Blood Stasis: An Overview. Evid Based Complement Alternat Med 2015; 2015: 316872.
3. Park YJ, Yang DH, Lee JM and Park YB. Deve-lopment of a valid and reliable blood stasis questionnaire and its relationship to heart rate variability. Complement Ther Med 2013; 21: 633-640.
4. Chen KJ. Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med 2012; 18: 891-896.
5. Jin X, Shen G, Gao F, Zheng X, Xu X, Shen F, Li G, Gong J, Wen L, Yang X and Bie X. Traditional Chinese drug ShuXueTong facilitates angiogenesis during wound healing following traumatic brain injury. J Ethnopharmacol 2008; 117: 473-477.
6. Du JP, Shi DZ, Li TC, Xu H and Chen H. [Cor-relation between blood stasis syndrome and pathological characteristics of coronary artery in patients with coronary heart disease]. Zhong Xi Yi Jie He Xue Bao 2010; 8: 848-852.
7. Tang H, Gu BL and Zhou XM. [Study on the scores of blood stasis syndrome of acute ischemic stroke and its correlation with TOAST subtypes]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 32: 1500-1502.
8. Liu P, Duan JA, Bai G and Su SL. [Network pharmacology study on major active compounds of siwu decoction analogous formulae for treating primary dysmenorrhea of gynecology blood stasis syndrome]. Zhongguo Zhong Yao Za Zhi 2014; 39: 113-120.
9. Yuan ZK, Wang LP and Huang XP. [The screening and the functional pathway analysis of differential genes correlated with coronary heart disease of blood stasis syndrome]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 32: 1313-1318.
10. Guo S, Chen J, Chuo W, Liu L, Feng X, Lian H, Zheng L, Wang Y, Xie H, Luo L, Zheng C, Fu B and Wang W. A New Biomarkers Feature Pattern Consisting of TNF-alpha, IL-10, and IL-8 for Blood Stasis Syndrome with Myocardial Ischemia. Evid Based Complement Alternat Med 2013; 2013: 130702.
11. Huang Y, Wang JS, Yin HJ and Chen KJ. The Expression of CD14(+)CD16(+) Monocyte Su-bpopulation in Coronary Heart Disease Pa-tients with Blood Stasis Syndrome. Evid Based Complement Alternat Med 2013; 2013: 416932.
12. Wang J and Yu G. A Systems Biology Approach to Characterize Biomarkers for Blood Stasis Syndrome of Unstable Angina Patients by Integrating MicroRNA and Messenger RNA Expression Profiling. Evid Based Complement Alternat Med 2013; 2013: 510208.
13. Wang J and Yu G. Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches. Chin J Integr Med 2014; 20: 163-169.
14. Allison AC. Turnovers of erythrocytes and plasma proteins in mammals. Nature 1960; 188: 37-40.
15. Chien S. Red cell deformability and its relevance to blood flow. Annu Rev Physiol 1987; 49: 177-192.
16. Diez-Silva M, Dao M, Han J, Lim CT and Suresh S. Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease. MRS Bull 2010; 35: 382-388.
17. de Oliveira S and Saldanha C. An overview about erythrocyte membrane. Clin Hemorheol Microcirc 2010; 44: 63-74.
18. Ando K, Beppu M and Kikugawa K. Evidence for accumulation of lipid hydroperoxides during the aging of human red blood cells in the circulation. Biol Pharm Bull 1995; 18: 659-663.
19. Mazzulla S, Schella A, Gabriele D, Baldino N, Sesti S, Perrotta E, Costabile A and de Cindio B. Oxidation of human red blood cells by a free radical initiator: Effects on rheological properties. Clin Hemorheol Microcirc 2014; [Epub ahead of print].
20. Tillmann W, Levin C, Prindull G and Schroter W. Rheological properties of young and aged human erythrocytes. Klin Wochenschr 1980; 58: 569-574.
21. Shiga T, Maeda N, Suda T, Kon K and Sekiya M. The decreased membrane fluidity of in vivo aged, human erythrocytes. A spin label study. Biochim Biophys Acta 1979; 553: 84-95.
22. Diamant M, Tushuizen ME, Sturk A and Nie-uwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34: 392-401.
23. Hugel B, Martinez MC, Kunzelmann C and Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 2005; 20: 22-27.
24. Manno S, Takakuwa Y and Mohandas N. Ide-ntification of a functional role for lipid asymmetry in biological membranes: Phospha-tidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci U S A 2002; 99: 1943-1948.
25. An X, Guo X, Sum H, Morrow J, Gratzer W and Mohandas N. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry 2004; 43: 310-315.
26. Bosman GJ, Werre JM, Willekens FL and Novotny VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-347.
27. Bosman GJ, Lasonder E, Groenen-Dopp YA, Willekens FL and Werre JM. The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. J Proteomics 2012; 76 Spec No.: 203-210.
28. Willekens FL, Werre JM, Groenen-Dopp YA, Roerdinkholder-Stoelwinder B, de Pauw B and Bosman GJ. Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol 2008; 141: 549-556.
29. Stewart A, Urbaniak S, Turner M and Bessos H. The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Tra-nsfusion 2005; 45: 1496-1503.
30. do Nascimento TS, Pereira RO, de Mello HL and Costa J. Methemoglobinemia: from diagnosis to treatment. Rev Bras Anestesiol 2008; 58: 651-664.
31. Hare GM, Tsui AK, Crawford JH and Patel RP. Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress-The example of anemia? Redox Biol 2013; 1: 65-69.
32. Signorini C, Ferrali M, Ciccoli L, Sugherini L, Magnani A and Comporti M. Iron release, me-mbrane protein oxidation and erythrocyte ageing. FEBS Lett 1995; 362: 165-170.
33. Arashiki N, Kimata N, Manno S, Mohandas N and Takakuwa Y. Membrane peroxidation and methemoglobin formation are both necessary for band 3 clustering: mechanistic insights into human erythrocyte senescence. Biochemistry 2013; 52: 5760-5769.
34. Stuart J and Nash GB. Red cell deformability and haematological disorders. Blood Rev 1990; 4: 141-147.
35. Pantely GA, Swenson LJ, Tamblyn CH, Seaman GV, Anselone CG, Johnson WB and Bristow JD. Increased vascular resistance due to a reduction in red cell deformability in the isolated hind limb of swine. Microvasc Res 1988; 35: 86-100.
36. Cabrales P. Effects of erythrocyte flexibility on microvascular perfusion and oxygenation during acute anemia. Am J Physiol Heart Circ Physiol 2007; 293: H1206-1215.
37. Owens AP, 3rd and Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284-1297.
38. Rubin O, Delobel J, Prudent M, Lion N, Kohl K, Tucker EI, Tissot JD and Angelillo-Scherrer A. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion 2013; 53: 1744-1754.
39. Radomski MW, Palmer RM and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-1058.
40. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756-762.
41. Schafer A, Wiesmann F, Neubauer S, Eigen-thaler M, Bauersachs J and Channon KM. Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 2004; 109: 1819-1822.
42. Ignarro LJ, Buga GM, Wood KS, Byrns RE and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84: 9265-9269.
43. Ignarro LJ, Byrns RE, Buga GM and Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-879.
44. Palmer RM, Ferrige AG and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Na-ture 1987; 327: 524-526.
45. Palmer RM, Ashton DS and Moncada S. Va-scular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
46. Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, Johnson KA, Smith RD, Phillips GN, Jr. and Olson JS. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996; 35: 6976-6983.
47. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP and Lemon DD. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004; 36: 685-697.
48. Vaughn MW, Huang KT, Kuo L and Liao JC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 2000; 275: 2342-2348.
49. Deonikar P and Kavdia M. Contribution of membrane permeability and unstirred layer diffusion to nitric oxide-red blood cell interaction. J Theor Biol 2013; 317: 321-330.
50. Butler AR, Megson IL and Wright PG. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta 1998; 1425: 168-176.
51. Liao JC, Hein TW, Vaughn MW, Huang KT and Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A 1999; 96: 8757-8761.
52. Donadee C, Raat NJ, Kanias T, Tejero J, Lee JS, Kelley EE, Zhao X, Liu C, Reynolds H, Azarov I, Frizzell S, Meyer EM, Donnenberg AD, Qu L, Triulzi D, Kim-Shapiro DB and Gladwin MT. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-476.
53. Liu C, Zhao W, Christ GJ, Gladwin MT and Kim-Shapiro DB. Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med 2013; 65: 1164-1173.
54. Haymond S, Cariappa R, Eby CS and Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem 2005; 51: 434-444.
55. Khandelwal S and Saxena RK. Assessment of survival of aging erythrocyte in circulation and attendant changes in size and CD147 expression by a novel two step biotinylation method. Exp Gerontol 2006; 41: 855-861.
56. Gokdemir MT, Sogut O, Kaya H, Sayhan MB, Cevik M, Dokuzoglu MA and Boleken ME. Role of oxidative stress in the clinical outcome of patients with multiple blunt trauma. J Int Med Res 2012; 40: 167-173.
57. Rana SV, Kashinath D, Singh G, Pal R and Singh R. Study on oxidative stress in patients with abdominal trauma. Mol Cell Biochem 2006; 291: 161-166.
58. Oldham KM, Wise SR, Chen L, Stacewicz-Sapuntzakis M, Burns J and Bowen PE. A longitudinal evaluation of oxidative stress in trauma patients. JPEN J Parenter Enteral Nutr 2002; 26: 189-197.
59. Laplace C, Huet O, Vicaut E, Ract C, Martin L, Benhamou D and Duranteau J. Endothelial oxidative stress induced by serum from patients with severe trauma hemorrhage. Intensive Care Med 2005; 31: 1174-1180.
60. Vina J, Gomez-Cabrera MC, Lloret A, Marquez R, Minana JB, Pallardo FV and Sastre J. Free radicals in exhaustive physical exercise: mechanism of production, and protection by antioxidants. IUBMB Life 2000; 50: 271-277.
61. Berzosa C, Gomez-Trullen EM, Piedrafita E, Cebrian I, Martinez-Ballarin E, Miana-Mena FJ, Fuentes-Broto L and Garcia JJ. Erythrocyte membrane fluidity and indices of plasmatic oxidative damage after acute physical exercise in humans. Eur J Appl Physiol 2011; 111: 1127-1133.
62. Xiong YL, Xiong YL, Li YJ, Tang FZ, Wang RF, Zhao YJ and Wang X. [Effects of exhaustive exercise-induced oxidative stress on red blood cell deformability]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2014; 30: 289-293.
63. Kameneva MV, Antaki JF, Borovetz HS, Griffith BP, Butler KC, Yeleswarapu KK, Watach MJ and Kormos RL. Mechanisms of red blood cell trauma in assisted circulation. Rheologic similarities of red blood cell transformations due to natural aging and mechanical stress. ASAIO J 1995; 41: M457-460.
64. Yen JH, Chen SF, Chern MK and Lu PC. The effect of turbulent viscous shear stress on red blood cell hemolysis. J Artif Organs 2014; 17: 178-185.
65. Koter M, Franiak I, Strychalska K, Broncel M and Chojnowska-Jezierska J. Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia. Int J Biochem Cell Biol 2004; 36: 205-215.
66. Dimeski G, Mollee P and Carter A. Increased lipid concentration is associated with incre-ased hemolysis. Clin Chem 2005; 51: 2425.
67. Broncel M, Balcerak M, Bala A, Koter-Michalak M, Duchnowicz P and Chojnowska-Jezierska J. [The erythrocyte membrane structure in patients with mixed hyperlipidemia]. Wiad Lek 2007; 60: 4-9.
68. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem 1989; 264: 21340-21345.
69. Resmi H, Akhunlar H, Temiz Artmann A and Guner G. In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct 2005; 23: 163-168.
70. Mohanty JG, Nagababu E and Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol 2014; 5: 84.
71. Vaya A, Rivera L, de la Espriella R, Sanchez F, Suescun M, Hernandez JL and Facila L. Red blood cell distribution width and erythrocyte deformability in patients with acute myocardial infarction. Clin Hemorheol Microcirc 2015; 59: 107-14.
72. Keymel S, Heiss C, Kleinbongard P, Kelm M and Lauer T. Impaired red blood cell deformability in patients with coronary artery disease and diabetes mellitus. Horm Metab Res 2011; 43: 760-765.
73. Reid HL, Dormandy JA, Barnes AJ, Lock PJ and Dormandy TL. Impaired red cell deformability in peripheral vascular disease. Lancet 1976; 1: 666-668.
74. Shin S, Ku YH, Ho JX, Kim YK, Suh JS and Singh M. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin Hemorheol Mic-rocirc 2007; 36: 253-261.
75. Brown CD, Ghali HS, Zhao Z, Thomas LL and Friedman EA. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int 2005; 67: 295-300.
76. Blum A. The possible role of red blood cell microvesicles in atherosclerosis. Eur J Intern Med 2009; 20: 101-105.
77. Giannopoulos G, Oudatzis G, Paterakis G, Synetos A, Tampaki E, Bouras G, Hahalis G, Alexopoulos D, Tousoulis D, Cleman MW, Ste-fanadis C and Deftereos S. Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty. Int J Cardiol 2014; 176: 145-150.
78. Gao C, Xie R, Yu C, Wang Q, Shi F, Yao C, Xie R, Zhou J, Gilbert GE and Shi J. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 2012; 107: 681-689.
79. Issberner U, Reeh PW and Steen KH. Pain due to tissue acidosis: a mechanism for inflammatory and ischemic myalgia? Neurosci Lett 1996; 208: 191-194.
80. Naves LA and McCleskey EW. An acid-sensing ion channel that detects ischemic pain. Braz J Med Biol Res 2005; 38: 1561-1569.